Poly(3-hydroxybutyrate-co-ε-caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-ε-caprolactone) terpolymers as novel materials for colloidal drug delivery systems

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 3-4, 2009, Pages 451-462

  Pignatello, Rosario ^a   Musumeci, Teresa ^a   Impallomeni, Giuseppe ^b   Carnemolla, Giovanni Marco ^a   Puglisi, Giovanni ^a   Ballistreri, Alberto ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Istituto di Chimica e Tecnologia dei Polimeri   (Italy)

Author keywords

Fluorescent probes; Microparticles; Nanoparticles; P(HB co CL); P(HB co HV co CL); Polyhydroxyalkanoates; Solvent deposition method

Indexed keywords

CALCEIN; FLUORESCENT DYE; NANOCARRIER; OIL RED O; POLY(3 HYDROXYBUTYRATE CO 3 HYDROXYVALERATE CO EPSILON CAPROLACTONE)TERPOLYMER; POLY(3 HYDROXYBUTYRATE CO EPSILON CAPROLACTONE)COPOLYMER; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG HYDROLYSIS; DRUG STABILITY; DRUG STORAGE; IN VITRO STUDY; MOLECULAR WEIGHT; NANOENCAPSULATION; NANOFABRICATION; PARTICLE SIZE; PRIORITY JOURNAL; ROOM TEMPERATURE; SURFACE CHARGE; SUSPENDED PARTICULATE MATTER; TECHNIQUE;

AZO COMPOUNDS; COLLOIDS; COLORING AGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FLUORESCEINS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; SOLUBILITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 67349283379     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.03.017     Document Type: Article

References (43)

1. Abe H., Doi Y., Aoki H., Akehata T., Hori Y., and Yamaguchi A. Physical properties and enzymatic degradability of copolymers of (R)-3-hydroxybutyric and 6-hydroxyhexanoic acids. Macromolecules 28 (1995) 7630-7637
2. Abe H., Doi Y., and Kumagai Y. Synthesis and characterization of poly (R,S)-3-hydroxybutyrate-b-6-hydroxyhexanoate as a compatibilizer for a biodegradable blend of poly (R)-3-hydroxybutyrate and poly(6-hydroxyhexanoate). Macromolecules 27 (1994) 6012-6017
3. Alexander C. Synthetic polymer systems in drug development. Expert Opin. Emerging Drugs 6 (2001) 331-343
4. Anderson A.J., and Dawes E.A. Occurrence, metabolism, metabolic role, and industrial uses of bacterial polyhydroxyalkanoates. Microbiol. Rev. 54 (1990) 450-472
5. Barichello J.M., Morishita M., Takayama K., and Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharm. 25 (1999) 471-476
6. Bougard F., Giacomelli C., Mespouille L., Borsali R., Dubois P., and Lazzaroni R. Influence of the macromolecular architecture on the self-assembly of amphiphilic copolymers based on poly(N,N-dimethylamino-2-ethyl methacrylate) and poly(epsilon-caprolactone). Langmuir 24 (2008) 8272-8279
7. Calvo P., Alonso M.J., Vila-Jato J.L., and Robinson J.R. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J. Pharm. Pharmacol. 48 (1996) 1147-1152
8. Cerrai P., Guerra G.D., Tricoli M., Krajewski A., Guicciardi S., Ravaglioli A., Maltinti S., and Masetti G. New composites of hydroxyapatite and bioresorbable macromolecular material. J. Mater. Sci.: Mater. Med. 10 (1999) 283-289
9. 13C-NMR. Polymer 24 (1983) 53-59
10. Chiellini F., Piras A.M., Errico C., and Chiellini E. Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. Nanomedicine 3 (2008) 367-393
11. Da Silveira A.M., Ponchel G., Puisieux F., and Duchene D. Combined poly(isobutylcyanoacrylate)/cyclodextrins for enhancing the encapsulation of lipophilic drugs. Pharm. Res. 15 (1998) 1051-1055
12. Doi Y. Microbial Polyesters (1990), VCH, New York
13. Eliyahu H., Barenholz Y., and Domb A.J. Polymers for DNA delivery. Molecules 10 (2005) 34-64
14. Galindo-Rodriguez S.A., Allemann E., Fessi H., and Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit. Rev. Ther. Drug Carrier Syst. 22 (2005) 419-464
15. Huang M.-H., Li S., Hutmacher D.W., Coudane J., and Vert M. Degradation characteristics of poly(ε-caprolactone)-based copolymers and blends. J. Appl. Polym. Sci. 102 (2006) 1681-1687
16. Impallomeni G., Giuffrida M., Barbuzzi T., Musumarra G., and Ballistreri A. Acid catalyzed transesterification as a route to poly(3-hydroxybutyrate-co-ε-caprolactone) copolymers from their homopolymers. Biomacromolecules 3 (2002) 835-840
17. Jang J.S., Kim S.Y., Lee S.B., Kim K.O., Han J.S., and Lee Y.M. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection. J. Control. Release 113 (2006) 173-182
18. Jiang W., Kim B.Y., Rutka J.T., and Chan W.C. Advances and challenges of nanotechnology-based drug delivery systems. Expert Opin. Drug Deliv. 4 (2007) 621-633
19. Juni K., and Nakano M. Poly(hydroxy acids) in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 3 (1987) 209-232
20. Kipp J.E. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm. 284 (2004) 109-122
21. Kim J.H., and Bae Y.H. Albumin loaded microsphere of amphiphilic poly(ethylene glycol)/poly(alpha-ester) multiblock copolymer. Eur. J. Pharm. Sci. 23 (2004) 245-251
22. Lemmouchi Y., Schacht E., Kageruka P., De Deken R., Diarra B., Diall O., and Geerts S. Biodegradable polyesters for controlled release of trypanocidal drugs: in vitro and in vivo studies. Biomaterials 19 (1998) 1827-1837
23. Li S., Liu L., Garreau H., and Vert M. Lipase-catalyzed biodegradation of poly(epsilon-caprolactone) blended with various polylactide-based polymers. Biomacromolecules 4 (2003) 372-377
24. Li S.M., Espartero J.L., Foch P., and Vert M. Structural characterization and hydrolytic degradation of a Zn metal initiated copolymer of l-lactide and epsilon-caprolactone. J. Biomater. Sci. Polym. Ed. 8 (1996) 165-187
25. Lince F., Marchisio D.L., and Barresi A.A. Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications. J. Colloid Interface Sci. 322 (2008) 505-515
26. Mohamed F., and van der Walle C.F. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J. Pharm. Sci. 97 (2008) 71-87
27. Mundargi R.C., Babu V.R., Rangaswamy V., Patel P., and Aminabhavi T.M. Nano/micro technologies for delivering macromolecular therapeutics using poly(d, l-lactide-co-glycolide) and its derivatives. J. Control. Release 125 (2008) 193-209
28. Musumeci T., Ventura C.A., Giannone I., Ruozi B., Montenegro L., Pignatello R., and Puglisi G. PLA/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm. 325 (2006) 172-179
29. Oda Y., Asari H., Urakami T., and Tonomura K. Microbial degradation of poly(3-hydroxybutyrate) and polycaprolactone by filamentous fungi. J. Ferment. Bioeng. 80 (1995) 265-269
30. Pinto Reis C., Neufeld R.J., Ribeiro A.J., and Veiga F. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine 2 (2006) 53-65
31. Pitt C.G. Nonmicrobial degradation of polyesters: mechanisms and modifications. In: Vert M., et al. (Ed). Biodegradable Polymers and Plastics (1992), The Royal Society of Chemistry, Cambridge 7-17
32. Pitt C.G., and Schlinder A. Capronor-a biodegradable delivery system for levonorgestrel. In: Zatuchni G.L., et al. (Ed). Long-acting Contraceptive Delivery Systems (1984), Harper and Row, Philadelphia 48-63
33. Pouton C.W., and Akhtar S. Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Adv. Drug Deliv. Rev. 18 (1996) 133-162
34. Schaffazick S.R., Pohlmann A.R., Dalla-Costa T., and Guterres S.S. Freeze-drying polymeric colloidal suspensions: nanocapsules, nanospheres and nanodispersion: a comparative study. Eur. J. Pharm. Biopharm. 56 (2003) 501-505
35. Shi Y., and Li L.C. Current advances in sustained-release systems for parenteral drug delivery. Expert Opin. Drug Deliv. 2 (2005) 1039-1058
36. Sinha V.R., Bansal K., Kaushik R., Kumria R., and Trehan A. Poly-ε-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 278 (2004) 1-23
37. Tosi G., Costantino L., Ruozi B., Forni F., and Vandelli M.A. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin. Drug Deliv. 5 (2008) 155-174
38. Uchegbu I.F., and Schatzlein A.G. Polymers in Drug Delivery (2006), CRC Press, Boca Raton
39. Wang F., Bronich T.K., Kabanov A.V., Rauh R.D., and Roovers J. Synthesis and characterization of star poly(epsilon-caprolactone)-b-poly(ethylene glycol) and poly(l-lactide)-b-poly(ethylene glycol) copolymers: evaluation as drug delivery carriers. Bioconjug. Chem. 19 (2008) 1423-1429
40. Wang Y., Chang H.-I., Wertheim D.F., Jones A.S., Jackson C., and Coombes A.G.A. Characterisation of the macroporosity of polycaprolactone-based biocomposites and release kinetics for drug delivery. Biomaterials 28 (2007) 4619-4627
41. Wu C., and Gan Z.H. A novel method of studying polymer degradation. Polymer (1998) 4429-4431
42. Yamadera R., and Murano M. The determination of randomness in copolyesters by high resolution nuclear magnetic resonance. J. Polym. Sci. Part A-1 5 (1967) 2259-2268
43. Yih T.C., and Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 97 (2006) 1184-1190